Drug discovery > Basic Research Products & Reviews

Products, services, reviews and techniques used in the preliminary investigations of the disease; the cell biology, genetics and protein pathways using tissue culture, cloning and imaging.

Product Filter

Drug discovery > Basic Research
Browse by Techniques
KRISHGEN BioSystems

Ratings

Search


KRIBIOLISA™ Eculizumab ELISA (SOLIRIS™)

KRISHGEN BioSystems

The Eculizumab (Soliris) ELISA kit is intended for the quantitative determination of Eculizumab (Soliris) in serum, plasma and cell culture samples. CE IVD marked. Key features: -uses highly specific monoclonal anti-idiotypic antibodies -calibrator used is commerically available eculizumab injection itself -Recovery: 80-120% -Precision CV

0.0/5.0
|0 Reviews
Request Pricing




KRIBIOLISA™ Catumaxomab ELISA (REMOVAB™)

KRISHGEN BioSystems

ELISA for the detection of Catumaxomab in human serum and plasma. Lead time for this kit is 5 weeks. About the kit: - Uses anti-idiotypic monoclonal antibodies sourced from our vendor partner in the US, which ensures higher specificity, and low cross reactivity. - Recovery rates are between 85 - 115% - Validated as per US FDA guidelines for Bioassays - Developed using the innovator drug as calibrator - Shelf life: 1 year

0.0/5.0
|0 Reviews
Request Pricing


KRIBIOLISA™ Glofitamab ELISA

KRISHGEN BioSystems

ELISA for the detection of Glofitamab in human serum and plasma. Lead time for this kit is 5 weeks. About the kit: - Uses anti-idiotypic monoclonal antibodies sourced from our vendor partner in the US, which ensures higher specificity, and low cross reactivity. - Recovery rates are between 85 - 115% - Validated as per US FDA guidelines for Bioassays - Developed using the innovator drug as calibrator - Shelf life: 1 year

0.0/5.0
|0 Reviews
Request Pricing

KRIBIOLISA™ Epcoritamab ELISA (DUOBODY-CD3xCD20)

KRISHGEN BioSystems

ELISA for the detection of Epcoritamab in human serum and plasma. Lead time for this kit is 5 weeks. About the kit: - Uses anti-idiotypic monoclonal antibodies sourced from our vendor partner in the US, which ensures higher specificity, and low cross reactivity. - Recovery rates are between 85 - 115% - Validated as per US FDA guidelines for Bioassays - Developed using the innovator drug as calibrator - Shelf life: 1 year

0.0/5.0
|0 Reviews
Request Pricing